Bobak Azamian
2020
In 2020, Bobak Azamian earned a total compensation of $2.5M as President, Chief Executive Officer and Director at Tarsus Pharmaceuticals.
Compensation breakdown
| Bonus | $211,484 |
|---|---|
| Option Awards | $1,847,092 |
| Salary | $437,000 |
| Other | $14,820 |
| Total | $2,510,396 |
Azamian received $1.8M in option awards, accounting for 74% of the total pay in 2020.
Azamian also received $211.5K in bonus, $437K in salary and $14.8K in other compensation.
Rankings
In 2020, Bobak Azamian's compensation ranked 4,538th out of 13,090 executives tracked by ExecPay. In other words, Azamian earned more than 65.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,538 out of 13,090 | 65th |
Division Manufacturing | 1,833 out of 5,621 | 67th |
Major group Chemicals And Allied Products | 713 out of 2,254 | 68th |
Industry group Drugs | 611 out of 1,954 | 69th |
Industry Biological Products, Except Diagnostic Substances | 143 out of 411 | 65th |
Source: SEC filing on May 2, 2022.